306 related articles for article (PubMed ID: 19402065)
1. Prognostic factors for survival in metastatic renal cell carcinoma: update 2008.
Bukowski RM
Cancer; 2009 May; 115(10 Suppl):2273-81. PubMed ID: 19402065
[TBL] [Abstract][Full Text] [Related]
2. Prognostic biomarkers in renal cell carcinoma.
Jiang Z
Expert Rev Mol Diagn; 2007 May; 7(3):293-307. PubMed ID: 17489736
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors and molecular markers for renal cell carcinoma.
Bui MH; Zisman A; Pantuck AJ; Han KR; Wieder J; Belldegrun AS
Expert Rev Anticancer Ther; 2001 Dec; 1(4):565-75. PubMed ID: 12113089
[TBL] [Abstract][Full Text] [Related]
4. Molecular signatures of localized clear cell renal cell carcinoma to predict disease-free survival after nephrectomy.
Klatte T; Seligson DB; LaRochelle J; Shuch B; Said JW; Riggs SB; Zomorodian N; Kabbinavar FF; Pantuck AJ; Belldegrun AS
Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):894-900. PubMed ID: 19240241
[TBL] [Abstract][Full Text] [Related]
5. Clinical and molecular prognostic factors in renal cell carcinoma: what we know so far.
Tang PA; Vickers MM; Heng DY
Hematol Oncol Clin North Am; 2011 Aug; 25(4):871-91. PubMed ID: 21763972
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors for cases with metastatic renal cell carcinoma in the era of targeted medicine.
Neuzillet Y; Culine S; Patard JJ
Int J Urol; 2009 Nov; 16(11):855-61. PubMed ID: 19674168
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors in patients with advanced renal cell carcinoma: development of an international kidney cancer working group.
Bukowski RM; Negrier S; Elson P
Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6310S-4S. PubMed ID: 15448023
[TBL] [Abstract][Full Text] [Related]
8. [Critical analysis of prognostic factors for metastatic renal cell carcinoma].
Neuzillet Y; Coulange C
Prog Urol; 2009 Jun; 19(6):383-8. PubMed ID: 19467456
[TBL] [Abstract][Full Text] [Related]
9. Prognostic models and algorithms in renal cell carcinoma.
Lane BR; Kattan MW
Urol Clin North Am; 2008 Nov; 35(4):613-25; vii. PubMed ID: 18992615
[TBL] [Abstract][Full Text] [Related]
10. High-dose interleukin-2 in metastatic renal cell carcinoma.
Fernández-Rodríguez R; de Argumedo GL; Mañé JM; Muñoz A; Ferreiro J; Fuente N; López-Vivanco G
J Clin Oncol; 2005 Sep; 23(27):6797-8; author reply 6798-9. PubMed ID: 16170190
[No Abstract] [Full Text] [Related]
11. Editorial comment on: Impact of C-reactive protein kinetics on survival of patients with metastatic renal cell carcinoma.
Novara G
Eur Urol; 2009 May; 55(5):1153-4. PubMed ID: 18930580
[No Abstract] [Full Text] [Related]
12. Characterization of primary renal carcinoma cultures.
Sievers E; Dreimuller P; Haferkamp A; Schmidt-Wolf IG; Buchler MW; Schmidt J; Marten A
Urol Int; 2007; 79(3):235-43. PubMed ID: 17940356
[TBL] [Abstract][Full Text] [Related]
13. Prediction of response to combined immunotherapy with interferon-alpha and low-dose interleukin-2 in metastatic renal cell carcinoma: expression patterns of potential molecular markers in radical nephrectomy specimens.
Miyake H; Sakai I; Muramaki M; Kurahashi T; Takenaka A; Fujisawa M
Int J Urol; 2009 May; 16(5):465-71. PubMed ID: 19467119
[TBL] [Abstract][Full Text] [Related]
14. Prognostic markers in renal cell carcinoma.
Ljungberg B
Curr Opin Urol; 2007 Sep; 17(5):303-8. PubMed ID: 17762621
[TBL] [Abstract][Full Text] [Related]
15. Deal watch: Aveo and Astellas to develop VEGF inhibitor for renal cell carcinoma.
Nat Rev Drug Discov; 2011 Apr; 10(4):248. PubMed ID: 21455225
[No Abstract] [Full Text] [Related]
16. Prognostic factors in renal cell carcinoma.
Shuch BM; Lam JS; Belldegrun AS; Figlin RA
Semin Oncol; 2006 Oct; 33(5):563-75. PubMed ID: 17045085
[TBL] [Abstract][Full Text] [Related]
17. Natural history of renal cell carcinoma.
Paulson DF
Semin Urol Oncol; 1996 Nov; 14(4):203-7. PubMed ID: 8946618
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic and prognostic molecular markers in renal cell carcinoma.
Tunuguntla HS; Jorda M
J Urol; 2008 Jun; 179(6):2096-102. PubMed ID: 18423738
[TBL] [Abstract][Full Text] [Related]
19. New treatment approaches in renal cell carcinoma.
Facchini G; Perri F; Caraglia M; Pisano C; Striano S; Marra L; Fiore F; Aprea P; Pignata S; Iaffaioli RV
Anticancer Drugs; 2009 Nov; 20(10):893-900. PubMed ID: 19752718
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic molecular markers for renal cell carcinoma: a critical appraisal of the current state of research and clinical applicability.
Eichelberg C; Junker K; Ljungberg B; Moch H
Eur Urol; 2009 Apr; 55(4):851-63. PubMed ID: 19155123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
